AstraZeneca advances response to global COVID-19 challenge as it receives first commitments for Oxford’s potential new vaccine

Back to overview

Swe-Cham Patron Member AstraZeneca: We are so proud to be collaborating with the University of Oxford to turn their ground-breaking work into a medicine that can be produced on a global scale. We are working on a number of agreements in parallel to ensure broad and equitable supply of the hashtag#COVID19 vaccine throughout the world at no profit during the pandemic. We are pleased to announce an agreement with the US Government:

Photo: Pascal Soriot CEO AstraZeneca